These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19274983)

  • 1. Corticosteroids for treating nerve damage in leprosy. A Cochrane review.
    van Veen NH; Nicholls PG; Smith WC; Richardus JH
    Lepr Rev; 2008 Dec; 79(4):361-71. PubMed ID: 19274983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroids for treating nerve damage in leprosy.
    Van Veen NH; Nicholls PG; Smith WC; Richardus JH
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005491. PubMed ID: 17443594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decompressive surgery for treating nerve damage in leprosy. A Cochrane review.
    Van Veen NH; Schreuders TA; Theuvenet WJ; Agrawal A; Richardus JH
    Lepr Rev; 2009 Mar; 80(1):3-12. PubMed ID: 19472848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids for treating nerve damage in leprosy.
    Van Veen NH; Nicholls PG; Smith WC; Richardus JH
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD005491. PubMed ID: 27210895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3).
    Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):311-8. PubMed ID: 14750576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leprosy type 1 (reversal) reactions and their management.
    Walker SL; Lockwood DN
    Lepr Rev; 2008 Dec; 79(4):372-86. PubMed ID: 19274984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2).
    Van Brakel WH; Anderson AM; Withington SG; Croft RP; Nicholls PG; Richardus JH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):300-10. PubMed ID: 14750575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the 'TRIPOD' trials.
    Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):319-27. PubMed ID: 14750577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-centre, double blind, randomized trial of three steroid regimens in the treatment of type-1 reactions in leprosy.
    Rao PS; Sugamaran DS; Richard J; Smith WC
    Lepr Rev; 2006 Mar; 77(1):25-33. PubMed ID: 16715687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexplained delayed nerve impairment in leprosy after treatment.
    Rosenberg NR; Faber WR; Vermeulen M
    Lepr Rev; 2003 Dec; 74(4):357-65. PubMed ID: 14750581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of corticosteroid usage combined with multidrug therapy on nerve damage assessed using nerve conduction studies: a prospective cohort study of 365 untreated multibacillary leprosy patients.
    Capadia GD; Shetty VP; Khambati FA; Ghate SD
    J Clin Neurophysiol; 2010 Feb; 27(1):38-47. PubMed ID: 20087206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two randomized controlled clinical trials to study the effectiveness of prednisolone treatment in preventing and restoring clinical nerve function loss in leprosy: the TENLEP study protocols.
    Wagenaar I; Brandsma W; Post E; van Brakel W; Lockwood D; Nicholls P; Saunderson P; Smith C; Wilder-Smith E; Richardus JH
    BMC Neurol; 2012 Dec; 12():159. PubMed ID: 23249098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decompressive surgery for treating nerve damage in leprosy.
    Van Veen NH; Schreuders TA; Theuvenet WJ; Agrawal A; Richardus JH
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006983. PubMed ID: 19160310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of corticosteroid usage on the bacterial killing, clearance and nerve damage in leprosy: a prospective cohort study: part 1--study design and baseline findings of 400 untreated multibacillary patients.
    Khambati FA; Shetty VP; Ghate SD; Capadia GD; Pai VV; Ganapati R
    Lepr Rev; 2008 Jun; 79(2):134-53. PubMed ID: 18711936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve damage in leprosy and its management.
    Wilder-Smith EP; Van Brakel WH
    Nat Clin Pract Neurol; 2008 Dec; 4(12):656-63. PubMed ID: 19002133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decompressive surgery for treating nerve damage in leprosy.
    Van Veen NH; Schreuders TA; Theuvenet WJ; Agrawal A; Richardus JH
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD006983. PubMed ID: 23235638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment duration of reversal reaction: a reappraisal. Back to the past.
    Naafs B
    Lepr Rev; 2003 Dec; 74(4):328-36. PubMed ID: 14750578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Controlled Double Blind Trial of Ciclosporin versus Prednisolone in the Management of Leprosy Patients with New Type 1 Reaction, in Ethiopia.
    Lambert SM; Alembo DT; Nigusse SD; Yamuah LK; Walker SL; Lockwood DN
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004502. PubMed ID: 27046330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field treatment of acute nerve function impairment in leprosy using a standardized corticosteroid regimen--first year's experience with 100 patients.
    Croft RP; Richardus JH; Smith WC
    Lepr Rev; 1997 Dec; 68(4):316-25. PubMed ID: 9503867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the change in clinical severity scale score and a retrospective physician assessment of neurological outcome in individuals with leprosy associated nerve function impairment after treatment with corticosteroids.
    Walker SL; Nicholls PG; Dhakal S; Hawksworth RA; Macdonald M; Mahat K; Ruchal S; Hamal S; Hagge DA; Neupane KD; Lockwood DN
    Lepr Rev; 2012 Jun; 83(2):154-63. PubMed ID: 22997691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.